BioClinica Expands Capabilities in Europe
BioClinica announced the opening of new and expanded offices in London and Munich.
BioClinica announced the opening of new and expanded offices in London and Munich. The facilities will offer clinical trial services including medical imaging, site training and support, and eClinical product lines. With a focus on medical imaging, the European offices will showcase an advanced image analysis center for BioClinica’s extensive network of European radiologists and imaging specialists. The expansion also provides resources for regional scientific and medical experts to assemble and deliver high quality central review of imaging data for multisite trials in Europe.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Roche’s Susvimo Lands FDA Approval for Diabetic Retinopathy Based on Phase III Pavilion Trial Data
May 22nd 2025One-year results from the Pavilion study showed patients who received Susvimo (ranibizumab) refilled every nine months achieved superior improvements on the Diabetic Retinopathy Severity Scale.
FDA Outlines Updated Requirement for Placebo-Controlled Trials in Vaccine Research
May 21st 2025In an article recently published by The New England Journal of Medicine, FDA higher-ups Vinay Prasad, MD, MPH; and Martin A. Makary, MD, MPH, wrote that any new COVID-19 vaccine must now be evaluated in placebo-controlled studies.
